Platform Technology Partners - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 100 filers reported holding SURFACE ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
Platform Technology Partners ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q2 2023$10,890
+41.7%
11,0000.0%0.01%
+25.0%
Q1 2023$7,687
-14.8%
11,0000.0%0.00%
-20.0%
Q4 2022$9,020
-18.0%
11,0000.0%0.01%
-16.7%
Q3 2022$11,000
-38.9%
11,0000.0%0.01%
-40.0%
Q2 2022$18,000
-43.8%
11,0000.0%0.01%
-33.3%
Q1 2022$32,000
-39.6%
11,0000.0%0.02%
-34.8%
Q4 2021$53,000
-30.3%
11,000
+10.0%
0.02%
-32.4%
Q3 2021$76,000
+1.3%
10,0000.0%0.03%
+9.7%
Q2 2021$75,00010,0000.03%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$22,297,0007.41%
ACT CAPITAL MANAGEMENT, LLC 170,500$1,291,0000.67%
SummerHaven Investment Management, LLC 128,078$970,0000.57%
Parkman Healthcare Partners LLC 248,267$1,879,0000.48%
SILVERARC CAPITAL MANAGEMENT, LLC 50,000$379,0000.21%
C M BIDWELL & ASSOCIATES LTD 33,030$250,0000.17%
ARK Investment Management 4,618,354$34,961,0000.08%
Knights of Columbus Asset Advisors LLC 114,594$867,0000.08%
Orbimed Advisors 909,666$6,886,0000.08%
HighVista Strategies LLC 13,932$105,0000.07%
View complete list of SURFACE ONCOLOGY INC shareholders